TAIPEI, Taiwan & NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- SL BIO Ltd. ("SL Bio" or the “Company”), a biomedical company specializing in developing innovative cellular and gene therapies, and Horizon Space Acquisition II Corp. (Nasdaq: HSPT) ("HSPT"), a publicly traded special purpose acquisition company , today announced that the registration statement on Form F-4 (the “Registration Statement”), in connection with HSPT’s previously announced proposed business combination (the “Business Combination”) with ...